The Role of Different Molecular Markers in Papillary Thyroid Cancer Patients with Acromegaly

Keskin F. E., Ozkaya H. M., Ferahman S., Haliloglu O., Karatas A., Aksoy F., ...Daha Fazla

Experimental and Clinical Endocrinology and Diabetes, cilt.127, sa.7, ss.437-444, 2019 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 127 Sayı: 7
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1055/a-0629-9223
  • Dergi Adı: Experimental and Clinical Endocrinology and Diabetes
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.437-444
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

Purpose Prevalence of papillary thyroid cancer (PTC) is increased in patients with acromegaly. We aimed to determine the protein expression of BRAF, RAS, RET, insulin like growth factor 1(IGF1), Galectine 3, CD56 in patients with PTC related acromegaly and to compare the extensity of these expressions with normal PTC patients and benign thyroid nodules.